GTx, Inc. to Participate in the Stifel 2017 Healthcare Conference

MEMPHIS, Tenn.--()--GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Stifel 2017 Healthcare Conference on Wednesday, November 15, 2017 at 9:30 am EST. The conference is being held at the Lotte New York Palace Hotel in New York City.

A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at http://www.gtxinc.com. A replay of the presentation will also be available and archived on the site for 30 days.

About GTx

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of serious medical conditions, including treatments for stress urinary incontinence and prostate cancer.

Contacts

Investors:
Argot Partners
Kimberly Minarovich or Sam Martin, 212-600-1902
or
Media:
Red House Consulting
Denise Powell, 510-703-9491
denise@redhousecomms.com

Contacts

Investors:
Argot Partners
Kimberly Minarovich or Sam Martin, 212-600-1902
or
Media:
Red House Consulting
Denise Powell, 510-703-9491
denise@redhousecomms.com